Maria Beatrice Passavanti

Prof. Maria Beatrice Passavanti

Department of Women, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples 80138, Italy
+2
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Caterina AurilioCaterina Aurilio
Caterina Aurilio
Pasquale SansonePasquale Sansone
Pasquale Sansone
MBManlio Barbarisi
Manlio Barbarisi
Vincenzo PotaVincenzo Pota
Vincenzo Pota
LGLuca Gregorio Giaccari
Luca Gregorio Giaccari
Maria Caterina PaceMaria Caterina Pace
Maria Caterina Pace
Carbapenem antibiotics are the most effective antimicrobials for the treatment of infections caused by the most resistant bacteria. They belong to the category of β-lactams that include the penicillins, cephalosporins, monobactams and carbapenems. This class of antimicrobials has a broader spectrum of activity than most other beta-lactams antibiotics and are the most effective against Gram-positive and Gram-negative bacteria. All β-lactams antibiotics have a similar molecular structure: the carbapenems together with the β-lactams. This combination gives an extraordinary stability to the molecule against the enzymes inactivating the β-lactams. They are safe to use and therefore widespread use in many countries has given rise to carbapenem resistance which is a major global public health problem. The carbapenem resistance in some species is intrinsic and consists of the capacity to resist the action of antibiotics with several mechanisms: for the absence of a specific target, or an intrinsic difference in the composition of cytoplasmatic membrane or the inability to cross the outer membrane. In addition to intrinsic resistance, bacteria can develop resistance to antibiotics with several mechanisms that can be gathered in three main groups. The first group includes antibiotics with poor penetration into the outer membrane of bacterium or antibiotic efflux. The second includes bacteria that modify the target of the antibiotics through genetic mutations or post-translational modification of the target. The third includes bacteria that act with enzyme-catalyzed modification and this is due to the production of beta-lactamases, that are able to inactivate carbapenems and so called carbapenemases. In this review, we focus on the mode of action of carbapenem and the mechanisms of carbapenem resistance.

16 December 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
Alfonso FiorelliAlfonso Fiorelli
Alfonso Fiorelli
FMFloriana Morgillo
Floriana Morgillo
RMRoberta Milione
Roberta Milione
Maria Caterina PaceMaria Caterina Pace
Maria Caterina Pace
Maria Beatrice PassavantiMaria Beatrice Passavanti
Maria Beatrice Passavanti
MSMario SANTINI
Mario SANTINI
Transcutaneous electrical nerve stimulation (TENS) has been used to control post-thoracotomy pain with contrasting results. We aimed to assess the efficacy of TENS on post-thoracotomy pain in relation of four criterion measurements as: (i) cytokines; (ii) pain; (iii) respiratory function and (iv) intake of narcotic medication. Between January 2008 and October 2010, 58 patients underwent standard posterolateral thoracotomy for resectable lung cancer. Fifty patients were enrolled in the present study and randomized in two groups: TENS group (25 patients) who received postoperatively TENS for 5 days and placebo group (25 patients) without TENS. In both groups (i) serum cytokines (IL-6, IL-10, TNF-α) were measured by ELISA before surgery and at 6, 12, 24, 48, 72, 96 and 120 postoperative hours (POHs); (ii) at the same POHs, the pain score was measured using visual analogue scale (VAS) ranging from 0 to 10 levels; (iii) respiratory function (FEV 1% and FVC % of predicted value) were valuated on 72, 96 and 120 POHs; (iv) the total intake of narcotic medication given during postoperative period of 5 days was recorded. Repeated measures of analysis of variance assess the difference between two study groups. A value of P < 0.05 was considered statistically significant. Of the 50 patients enrolled, two patients of TENS group and two patients of the placebo group were lost to follow-up. (i) Serum IL-6 (P = 0.001), IL-10 (P = 0.001) and TNF-α (P = 0.001) levels in TENS group were significantly lower than in the control group; (ii) VAS score in TENS group was significantly lower than in the control group (P < 0.001); (iii) recovery of FEV 1 (P = 0.02) and of FVC (P = 0.02) was statistically better in the TENS group than in control group; (iv) morphine requirement was lower in the TENS group with respect to placebo TENS (P = 0.004). After 48 POHs, no patient required supplementary dose of morphine. TENS group compared with placebo-group presented a significant reduction of non-opioid consumption (P = 0.002). TENS is a valuable strategy to alleviate post-thoracotomy pain with reduction of cytokine production and of analgesic consumption, and with positive effects on pulmonary ventilation function.

1 January 2015 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
MRMaria Rosaria Rizzo
Maria Rosaria Rizzo
FSFerdinando Carlo Sasso
Ferdinando Carlo Sasso
RMRaffaele Marfella
Raffaele Marfella
MSMario Siniscalchi
Mario Siniscalchi
Pasquale PaolissoPasquale Paolisso
Pasquale Paolisso
Giuseppe PaolissoGiuseppe Paolisso
Giuseppe Paolisso

15 June 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Maria Caterina PaceMaria Caterina Pace
Maria Caterina Pace
Maria Beatrice PassavantiMaria Beatrice Passavanti
Maria Beatrice Passavanti
LNLorenzo De Nardis
Lorenzo De Nardis
FBFabio Bosco
Fabio Bosco
Pasquale SansonePasquale Sansone
Pasquale Sansone
CACaterina Aurilio
Caterina Aurilio

1 June 2006 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Maria Caterina PaceMaria Caterina Pace
Maria Caterina Pace
LML. Mazzariello
L. Mazzariello
Maria Beatrice PassavantiMaria Beatrice Passavanti
Maria Beatrice Passavanti
Pasquale SansonePasquale Sansone
Pasquale Sansone
MBM. Barbarisi
M. Barbarisi
CAC. Aurilio
C. Aurilio

28 October 2017 in World Journal of Hepatology
Verified
Journal Article
Open access
Marco FioreMarco Fiore
Marco Fiore
Alberto MaraoloAlberto Maraolo
Alberto Maraolo
IGIvan Gentile
Ivan Gentile
GBGuglielmo Borgia
Guglielmo Borgia
SLSebastiano Leone
Sebastiano Leone
MPMaria Caterina Pace
Maria Caterina Pace
Spontaneous bacterial peritonitis (SBP) is the most common infection in end-stage liver disease patients. SBP is defined as an ascitic fluid infection with a polymorphonuclear leucocyte count ≥ 250/mm3 without an evident intra-abdominal surgically treatable source. Several mechanisms contribute to SBP occurrence, including translocation of gut bacteria and their products, reduced intestinal motility provoking bacterial overgrowth, alteration of the gut's barrier function and local immune responses. Historically, Gram-negative enteric bacteria have been the main causative agents of SBP, thereby guiding the empirical therapeutic choice. However, over the last decade, a worryingly increasing prevalence of Gram-positive and multi-drug resistant (MDR) SBP has been seen. Recently, the microbiological spectrum of SBP seems to have changed in Europe due to a high prevalence of Gram-positive bacteria (48%-62%). The overall proportion of MDR bacteria is up to 22%-73% of cases. Consequently, empirical therapy based on third-generation cephalosporins or amoxicillin/clavulanic acid, can no longer be considered the standard of care, as these drugs are associated with poor outcomes. The aim of this review is to describe, with an epidemiological focus, the evidence behind this rise in Gram-positive and MDR SBP from 2000 to present, and illustrate potential targeted therapeutic strategies. An appropriate treatment protocol should include daptomycin plus ceftaroline and meropenem, with prompt stepdown to a narrower spectrum when cultures and sensitivity data are available in order to reduce both cost and potential antibiotic resistance development.